Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma

被引:21
作者
Shin, Ha-Yeon [1 ]
Yang, Wookyeom [1 ]
Chay, Doo Byung [2 ]
Lee, Eun-ju [1 ]
Chung, Joon-Yong [3 ]
Kim, Hyun-Soo [4 ]
Kim, Jae-Hoon [1 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Dept Obstet & Gynecol, Coll Med, Seoul 06273, South Korea
[2] Sahmyook Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[3] NCI, Expt Pathol Lab, Pathol Lab, NIH, Bethesda, MD 20892 USA
[4] Sungkyunkwan Univ, Dept Pathol & Translat Genom, Samsung Med Ctr, Sch Med, Seoul 06351, South Korea
基金
新加坡国家研究基金会;
关键词
AMP-activated protein kinase; atypical endometriosis; endometriosis; ovarian clear cell carcinoma; tetraspanin; 1; AMPK ACTIVATION; CANCER; PROLIFERATION; PATHWAY; EXPRESSION; GROWTH; AKT;
D O I
10.1002/1878-0261.12884
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian clear cell carcinoma (OCCC) reportedly develops from endometriosis. However, the molecular mechanism underlying its malignant progression to OCCC remains elusive. This study aimed to identify an essential gene in the malignant transformation of endometriosis to OCCC. We performed RNA sequencing in formalin-fixed, paraffin-embedded (FFPE) tissues of endometriosis (n = 9), atypical endometriosis (AtyEm) (n = 18), adjacent endometriosis to OCCC (AdjEm) (n = 7), and OCCC (n = 17). We found that tetraspanin 1 (TSPAN1) mRNA level was significantly increased by 2.4- (DESeq2) and 3.4-fold (edgeR) in AtyEm and by 80.7- (DESeq2) and 101-fold (edgeR) in OCCC relative to endometriosis. We confirmed that TSPAN1 protein level was similarly overexpressed in OCCC tissues and cell lines. In immortalized endometriosis cell lines, TSPAN1 overexpression enhanced cell growth and invasion. Mechanistically, TSPAN1 triggered AMP-activated protein kinase (AMPK) activity, promoting endometriosis and cell growth. Upregulated levels of TSPAN1 are considered an early event in the development of high-risk endometriosis that could progress to ovarian cancer. Our study suggests the potential of TSPAN1 as a screening candidate for high-risk endometriosis.
引用
收藏
页码:987 / 1004
页数:18
相关论文
共 53 条
[1]   Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].
Agarwal, R ;
Kaye, SB .
NATURE REVIEWS CANCER, 2003, 3 (07) :502-516
[2]   Cancer-Associated Mutations in Endometriosis without Cancer [J].
Anglesio, M. S. ;
Papadopoulos, N. ;
Ayhan, A. ;
Nazeran, T. M. ;
Noe, M. ;
Horlings, H. M. ;
Lum, A. ;
Jones, S. ;
Senz, J. ;
Seckin, T. ;
Ho, J. ;
Wu, R. -C. ;
Lac, V. ;
Ogawa, H. ;
Tessier-Cloutier, B. ;
Alhassan, R. ;
Wang, A. ;
Wang, Y. ;
Cohen, J. D. ;
Wong, F. ;
Hasanovic, A. ;
Orr, N. ;
Zhang, M. ;
Popoli, M. ;
McMahon, W. ;
Wood, L. D. ;
Mattox, A. ;
Allaire, C. ;
Segars, J. ;
Williams, C. ;
Tomasetti, C. ;
Boyd, N. ;
Kinzler, K. W. ;
Gilks, C. B. ;
Diaz, L. ;
Wang, T. -L. ;
Vogelstein, B. ;
Yong, P. J. ;
Huntsman, D. G. ;
Shih, I. -M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (19) :1835-1848
[3]   KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay [J].
Auner, Veronika ;
Kriegshaeuser, Gernot ;
Tong, Dan ;
Horvat, Reinhard ;
Reinthaller, Alexander ;
Mustea, Alexander ;
Zeillinger, Robert .
BMC CANCER, 2009, 9
[4]   Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells [J].
Banu, Sakhila K. ;
Lee, JeHoon ;
Starzinski-Powitz, Anna ;
Arosh, Joe A. .
FERTILITY AND STERILITY, 2008, 90 (04) :972-987
[5]   ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors [J].
Berns, Katrien ;
Caumanns, Joseph J. ;
Hijmans, E. Marielle ;
Gennissen, Annemiek M. C. ;
Severson, Tesa M. ;
Evers, Bastiaan ;
Wisman, G. Bea A. ;
Meersma, Gert Jan ;
Lieftink, Cor ;
Beijersbergen, Roderick L. ;
Itamochi, Hiroaki ;
van der Zee, Ate G. J. ;
de Jong, Steven ;
Bernards, Rene .
ONCOGENE, 2018, 37 (33) :4611-4625
[6]   Novel three-dimensional in vitro models of ovarian endometriosis [J].
Brueggmann, Doerthe ;
Templeman, Claire ;
Starzinski-Powitz, Anna ;
Rao, Nagesh P. ;
Gayther, Simon A. ;
Lawrenson, Kate .
JOURNAL OF OVARIAN RESEARCH, 2014, 7
[7]   Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers [J].
Chan, John K. ;
Teoh, Deanna ;
Hu, Jessica M. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :370-376
[8]   Prognostic factors in epithelial ovarian cancer: A population-based study [J].
Chang, Lin-Chau ;
Huang, Chih-Fen ;
Lai, Mei-Shu ;
Shen, Li-Jiuan ;
Wu, Fe-Lin Lin ;
Cheng, Wen-Fang .
PLOS ONE, 2018, 13 (03)
[9]   Suppression of TSPAN1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro [J].
Chen, Li ;
Yuan, Daiyue ;
Zhao, Ren ;
Li, Hui ;
Zhu, Jianwei .
TUMORI JOURNAL, 2010, 96 (05) :744-750
[10]   The role of S100A14 in epithelial ovarian tumors [J].
Cho, Hanbyoul ;
Shin, Ha-Yeon ;
Kim, Sunghoon ;
Kim, Jane Seon-Young ;
Chung, Joon-Yong ;
Chung, Eun Joo ;
Chun, Kyung-Hee ;
Hewitt, Stephen M. ;
Kim, Jae-Hoon .
ONCOTARGET, 2014, 5 (11) :3482-3496